NRC Health (NRC)

From the record

NRC Health's filings since 2017 show 1 warning event: a notice about its exchange listing (8-K item 3.01, the latest 2018-04-20) (its current reports).

From the record

NRC Health's 9 filed years say what it did: revenue went from $118 million in fiscal 2017 to $137 million in fiscal 2025, up 2% a year; it rose in 5 of 8 years; the deepest fall was 9% from fiscal 2022 to fiscal 2025; net income was positive in 9 of 9 of those years (its annual reports).

From the record

Over the 3 fiscal years to 2025-12-31, NRC Health's diluted share count shrank about 3.7% a year, and dividends and buybacks returned about 100% of its operating cash flow over 3 years (its filed statements). Its officers and directors filed 0 sales and 1 purchase of their own stock on the open market in the year to 2026-11-12, buying about $98 thousand (their Form 4 filings).

From the record

Return on equity: in the fiscal year ended 2025-12-31, NRC Health earned about 83 cents of profit for every dollar of shareholders' money. Leverage: it owed about 90 cents per dollar of assets, and net share issuance: its share count shrank 5.7% over the year (the filed statements).

From the record

NRC Health's standing among 12 graded names in its industry family: revenue of $137 million in fiscal 2025 ranks in the top 46% by size; a net margin of 8.4% ranks in the top 21%; revenue growth of -3.2% a year over the last 3 filed years ranks in the bottom 38% (its annual reports).

From the record

NRC Health's leadership, from its insiders' filings and its current reports: no one files under a chief executive's title, so that part is not read; the 10 officers and directors filing in the last fifteen months have been on the record a median of 5.5 years (top 44%); 15 officer or director changes were reported on Form 8-K since 2023-11-13, against the 10 people in charge now (bottom 6%; fewer changes for each person reads higher) (the Form 4 record, its Form 8-K reports). Years count from a person's first filing in the SEC's data sets, which begin in 2006, so each is a floor.

From the record

NRC Health's room to grow, from the newest filed statements (fiscal 2025): cash of $4 million against debt of $75 million leaves -52.6% of its assets as net cash, bottom 4% of its family; cash from operations less capital spending is 11.5% of revenue (top 37%) (its annual report).

From the record

NRC Health's growth drivers, from the filed years to fiscal 2025: revenue grew -3.2% a year over the last three filed years against 2% over all 9, slowing (top 46% of its family); the newest year grew -4% (bottom 46%); capital spending grew 2.9% a year (top 12%) (its annual reports). NRC Health tags no split of its revenue by line in the annual report on file, so growth by line cannot be read here; research and capital spending are on the trend.

From the record

NRC Health's newest year against its own record: revenue of $137 million in fiscal 2025 came in 1.2% below the $139 million its prior three years' pace pointed to (top 50% of its family); net income of $12 million against a prior three-year average of $29 million (bottom 32%); a net margin of 8.4% against 19.7% before (bottom 41%) (its annual reports).